Atlas Trials

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Clinical trial NCT00266110 · COMPLETED

Trial details

NCT number
NCT00266110
Sponsor
UNC Lineberger Comprehensive Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2005-12-01
Primary completion
2013-02-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.